Seroprevalence of COVID-19 in Thailand

• Conditions: COVID-19 infection; COVID-19; Seroprevalence; Antibody; Thailand

• Registration Number: TCTR20200828001
• Lead Sponsor: one

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-28
• Study Completion: 2021-07-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

1. Age 20-60 years
2. Have been living in Bangkok since January 1 st 2020
3. Can communicate in Thai language

Exclusion Criteria

1. Took antiviral drugs within 30 days
2. Immunocompromised
3. Enrolled in other COVID-19 drug/vaccination research
4. Dementia
5. Mental retard

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Seroprevalence of COVID-19 antibody Month 0, Month 6, Month 12 SARS-CoV-2 IgM IgG antibody ELISA assay, neutralization anticody

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A